You just read:

CeloNova's COBRA PzF NanoCoated Coronary Stent (NCS) Being Studied with 14-day DAPT in High Bleeding Risk Patients

News provided by

CeloNova BioSciences, Inc.

26 Oct, 2017, 07:00 BST